BNET Industries

Inyx Inc.

(IYXI) is in the Pharma Industry

Market Cap:$159.3K
Last Fiscal Year Sales:$49.5M
  • Public
  • US
Dow Jones Description

Inyx, Inc. is a specialty pharmaceutical company with niche drug delivery technologies and products for the treatment of respiratory, allergy, dermatological, topical and cardiovascular conditions. Focusing on both prescription and over-the-counter pharmaceutical products, Inyx provides contract manufacturing and development services to the international healthcare market, including a number of the largest pharmaceutical companies in the world. In addition, we are utilizing our niche drug delivery capabilities to develop Inyx's own proprietary products, which will be marketed in collaboration with industry partners and through our wholly owned sales and marketing subsidiary Exaeris, Inc . Inyx is now a vertically integrated, specialty pharmaceutical organization ? with commercial and marketing resources as well as development and manufacturing operations ? to maximize our Company's niche drug delivery capabilities for the benefit of clients/partners and Inyx. Inyx's drug delivery expertise and technologies include: - Significant, proven experience and technology in the conversion from chlorofluorocarbon (CFC) to CFC-free aerosol pharmaceutical products. This conversion is mandated by the Montreal Protocol, an international agreement signed by 188 nations banning the use of ozone-depleting CFC pharmaceuticals by or before 2010. CFC is already banned in pharmaceutical products in Europe, Canada, Japan and many other countries; the United States, the world's largest market,...

President and Director
Steven Handley
Contact Information

825 Third Avenue

40th Floor

New York, New York 10022

www.inyxinc.com

212-838-1111

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

News & Analysis

inyx inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Steven Handley President and Director
Colin Hunter Executive Vice President, Chief Scientific Officer, and Director
Marc Couturier Senior Vice President Global Business Development
Bill Kelly Vice President, Investor Relations
David Zinn Vice President, Finance
Dolores Fernandez Vice President, Global Supply Chain
Jimmy Meade Vice President, Group Engineering Projects
Jose Betancourt Vice President, General Manager
Joseph Rose Vice President, Finance, Inyx Europe Ltd. & Inyx Pharma
Nancy Hernandez Vice President, Regulatory Compliance and Quality Operations
Phil Jenkinson Vice President, Quality
Rima Goldshmidt Vice President, Finance
Stephen Beckman Vice President, Sales & Marketing and Commercial Development
Tony Garcia Vice President, General Manager
Ulrich Bartke Vice President, Global Sales and Marketing
Jay M Green Executive Vice President and Director of Corporate Development
Anastasia Loftus Regulatory Affairs Manager
Carole Richardson Corporate Administration Manager
Malcolm Fox Engineering Manager
Serge Agueev Information Systems Manager
Eddie Prady Head of Quality, Ashton Pharmaceuticals, Ltd.
Norma Rosa Head of Finance
Tony Weeks Head of Operations, Ashton Pharmaceuticals, Ltd.

Organization Position Status
Inyx, Inc. President and Director Current

Mr. Hunter has over 25 years experience within the pharmaceutical industry where he has held senior positions in quality, manufacturing operations and supply chain management for Glaxo Pharmaceuticals, Evans Healthcare Ltd., Celltech/Medeva Group PLC, CCL Pharmaceuticals and Miza UK. He has extensive experience in quality affairs and regulatory matters with both the U.S. Food and Drug Administration and the European Regulatory Union. Mr. Hunter holds a Bachelor of Science Degree with Honors in Bacteriology and Virology. He is a Chartered Biologist, Member of the Institute of Biology and a Fellow of The Institute of Quality Assurance as well as a member of several other professional societies.

Organization Position Status
Inyx, Inc. Executive Vice President, Chief Scientific Officer, and Director Current
U.S. Food and Drug Administration Former

Organization Position Status
Inyx, Inc. Senior Vice President Global Business Development Current
Mitsubishi Corporation Former

Organization Position Status
Inyx, Inc. Vice President, Investor Relations Current

Organization Position Status
Inyx, Inc. Vice President, Finance Current
Electrolytic Technologies Corporation Chief Financial Officer Former
Florida International University M.S. In Taxation Former

Organization Position Status
Inyx, Inc. Vice President, Global Supply Chain Current

Organization Position Status
Inyx, Inc. Vice President, Group Engineering Projects Current

Organization Position Status
Inyx, Inc. Vice President, General Manager Current

Organization Position Status
Inyx, Inc. Vice President, Finance, Inyx Europe Ltd. & Inyx Pharma Current

Organization Position Status
Inyx, Inc. Vice President, Regulatory Compliance and Quality Operations Current

Organization Position Status
Inyx, Inc. Vice President, Quality Current

Ms. Goldshmidt directs Inyx's financial reporting and fiscal management. She has extensive experience in financial consulting services within the pharmaceutical industry. Prior to joining Inyx, she served as Director of Finance for Miza Pharmaceuticals, Inc. Earlier, she served as an audit manager at KPMG where she focused on serving clients in the life sciences industry. Ms. Goldshmidt is a Chartered Accountant with also a degree in Microbiology and Biochemistry from the University of Toronto.

Organization Position Status
University of Toronto Chartered Accountant Former
Inyx, Inc. Board of Directors Current

Organization Position Status
Inyx, Inc. Vice President, Sales & Marketing and Commercial Development Current
St. Joseph's University Adjunct Lecturer Current
Stovall Grainger Inc. Current
Exaeris Executive Board Member Current
The Healthcare Marketing & Communications Council, Inc. Board of Directors Current
The Healthcare Marketing & Communications Council, Inc. Member Current
Exaeris President Former
Corporate Marketing, Inc. Vice President Former
Marion Merrell Dow Former
Syracuse University B.S. In Marketing Former

Organization Position Status
Inyx, Inc. Vice President, General Manager Current

Organization Position Status
Inyx, Inc. Vice President, Global Sales and Marketing Current
Powderject Pharmaceuticals, Plc Former

Organization Position Status
Exaeris Executive Vice President. Current
Inyx, Inc. Executive Vice President and Director of Corporate Development Current
Exaeris Executive Board Member Current
Inyx, Inc. Investment Banker Former
NYSE Group, Inc. Executive Officer Former
Forest Laboratories, Inc. Former
Cardinal Health, Inc. Former

Organization Position Status
Inyx, Inc. Regulatory Affairs Manager Current

Organization Position Status
Inyx, Inc. Corporate Administration Manager Current

Organization Position Status
Inyx, Inc. Engineering Manager Current

Organization Position Status
Inyx, Inc. Information Systems Manager Current

Organization Position Status
Inyx, Inc. Head of Quality, Ashton Pharmaceuticals, Ltd. Current

Organization Position Status
Inyx, Inc. Head of Finance Current

Organization Position Status
Inyx, Inc. Head of Operations, Ashton Pharmaceuticals, Ltd. Current
advertisement
     IYXI $0.00 0.00 (0.00% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 101,948
Shares Outstanding 53.11M
Market Cap 159.3K
Year High 0.006
Year Low 0.0003
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement
Click Here